[{"Assets_0_FY_USD":5611068000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":285494000.0,"NetIncomeLoss_4_FY_USD":365614000.0,"NetIncomeLoss_1_FY_USD":-828500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":29836000.0,"StockholdersEquity_0_FY_USD":4020331000.0,"EarningsPerShareBasic_1_FY_USD":-27.73,"EarningsPerShareBasic_4_FY_USD":12.25,"Assets_0_Q1_USD":6862914000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":42943000.0,"NetIncomeLoss_1_Q1_USD":865195000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":29801000.0,"StockholdersEquity_0_Q1_USD":4863855000.0,"EarningsPerShareBasic_1_Q1_USD":29.03,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20190510"}]